UCLA to lead NIMH-financed autism drug discovery network

04/25/2013 | New York Times (tiered subscription model), The

The National Institute of Mental Health will fund a $9 million effort to develop drugs to treat autism spectrum disorders. Researchers at the University of California, Los Angeles, will coordinate a network of researchers at other academic centers who will quickly identify new and existing compounds that might work against autism. Robert H. Ring, vice president of translational research at patient advocacy group Autism Speaks, will be a member of the panel choosing compounds for testing.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA